Prelude Capital Management, LLC Pfizer Inc Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 57,069 shares of PFE stock, worth $1.53 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

57,069

Previous 57,069 -0.0%

Holding current value

$1.53 Million

Previous $1.65 Million -0.0%

% of portfolio

0.11%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $40,081 - $45,421	1,447 Added 2.6%	57,069 $1.65 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $75 - $88	3 Added 0.01%	55,622 $1.56 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $264,388 - $303,602	-10,212 Reduced 15.51%	55,619 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.45 Million - $1.89 Million	55,612 Added 544.2%	65,831 $1.9 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $35,170 - $41,110	1,096 Added 12.01%	10,219 $338,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $66,352 - $76,768	1,837 Added 25.21%	9,123 $334,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $320,949 - $417,829	-8,148 Reduced 52.79%	7,286 $297,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $914,158 - $1.19 Million	-21,896 Reduced 58.66%	15,434 $791,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $820,718 - $1 Million	18,755 Added 100.97%	37,330 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $1.17 Million - $1.38 Million	-25,093 Reduced 57.46%	18,575 $974,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1.03 Million - $1.28 Million	-22,520 Reduced 34.02%	43,668 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.67 Million - $2.48 Million	40,464 Added 157.3%	66,188 $3.91 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $781,271 - $1 Million	19,905 Added 342.07%	25,724 $1.11 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $1.44 Million - $1.63 Million	-40,144 Reduced 87.34%	5,819 $228,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $1.18 Million - $1.33 Million	35,303 Added 331.17%	45,963 $1.67 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $104,794 - $133,255	3,131 Added 41.59%	10,660 $392,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $239,045 - $280,455	7,529 New	7,529 $276,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.1 Million - $1.25 Million	-28,609 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $986,152 - $1.2 Million	28,609 New	28,609 $1.26 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Pfizer Inc Transaction History